Active drug targeting of disease by nanoparticles functionalized with ligand to folate receptor

Current Medicinal Chemistry

Volumn 19, Issue 19, 2012, Pages 3152-3162

  Tu, Q ^a   Zhang, Y ^a   Liu, R ^a   Wang, J C ^a   Li, L ^a   Nie, N ^a   Liu, A ^a   Wang, L ^a   Liu, W ^a   Ren, L ^a   Wang, X ^a   Wang, J ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

Cancer; Drug delivery system; Folate; Folate receptor; Nanoparticles

Indexed keywords

DOXORUBICIN; DRUG CARRIER; FOLATE RECEPTOR; NANOPARTICLE; PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; CANCER TISSUE; CHEMICAL STRUCTURE; CYTOTOXICITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG ENCAPSULATION; DRUG TARGETING; ENCAPSULATION; ENDOCYTOSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; REVIEW; VASCULARIZATION;

ANIMALS; DRUG DELIVERY SYSTEMS; FOLIC ACID; FOLIC ACID TRANSPORTERS; HUMANS; LIGANDS; NANOPARTICLES; NEOPLASMS;

EID: 84863658688     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712800784694     Document Type: Review

References (127)

1. Danhier, F.; Feron, O.; Préat, V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release, 2010, 148(2), 135-146.
2. Safavy, A.; Raisch, K.P.; Khazaeli, M.B.; Buchsbaum, D.J.; Bonner, J.A. Paclitaxel derivatives for targeted therapy of cancer: toward the development of smart taxanes. Med. Chem., 1999, 42(23), 4919-4924.
3. Blum, R.H.; Carter, S.H. Adriamycin: a new anticancer drug with significant clinical activity. Ann. Intern. Med., 1974, 80(2), 249-259.
4. Giovanella, B.C.; Hinz, H.R.; Kozielski, A.J. Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin. Cancer Res., 1991, 51(11), 3052-3055.
5. Ralf-Dietera, H.; Ulrikea, G.V.S.; Ulrichb, B.; Andreasa, H. Liposomal encapsulated anti-cancer drugs. Anti-Cancer Drugs, 2005, 16(7), 691-707.
6. Guo, M.; Que, C.; Wang, C.H.; Liu, X.Z.; Yan, H.S.; Liu, K.L. Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery. Biomaterials, 2011, 32(1), 185-194.
7. Phillips, M.A.; Gran, M.L.; Peppas, N.A. Targeted nanodelivery of drugs and diagnostics. Nano Today, 2010, 5(2), 143-159.
8. Li, X.; Ding, L.; Xu, Y.; Wang, Y.; Ping, Q. Targeted delivery of doxorubicin using stealth liposomes modified with transferring. Int. J. Pharm, 2009, 373(1-2), 116-123.
9. Lee, E.; Lee, J.; Lee, I.H.; Yu, M.; Kim, H.; Chae, S.Y.; Jon, S. Conjugated chitosan as a novel platform for oral delivery of paclitaxel. J. Med. Chem, 2008, 51(20), 6442-6449.
10. Ohulchanskyy, T.Y.; Roy, I.; Goswami, L.N.; Chen, Y.; Bergey, E.J.; Pandey, R.K.; Oseroff, A.R.; Prasad, P.N. Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer. Nano Lett., 2007, 7 (9), 2835-2842.
11. Kim, K.; Kim, J.H.; Park, H.; Kim, Y.S.; Park, K.; Nam, H.; Lee, S.; Park, J.H.; Park, R.W.; Kim, I.S.; Choi, K.; Kim, S.Y.; Park, K.; Kwon, I.C. Tumor-homing multifunctional nanoparticles for cancer theragnosis: simultaneous diagnosis, drug delivery, and therapeutic monitoring. J. Control. Release, 2010, 146(2), 219-227.
12. Ulbrich, K.; Subr, V. Polymeric anticancer drugs with pH-controlled activation. Adv. Drug Deliv. Rev., 2004, 56(7), 1023-1050.
13. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Deliv. Rev., 2002, 54(5), 631-651.
14. Choi, K.Y.; Chung, H.; Min, K.H.; Yoon, H.Y.; Kim, K.; Park, J.H.; Kwon, I.C.; Jeong, S.Y. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials, 2010, 31(1), 106-114.
15. ® H40, poly(L-lactide) and poly(ethylene glycol) for tumor targeted drug delivery. Biomaterials, 2009, 30(16), 3009-3019.
16. Lin, J.J.; Chen, J.S.; Huang, S.J.; Ko, J.H.; Wang, Y.M.; Chen, T.L.; Wang, L.F. Folic acid-Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications. Biomaterials, 2009, 30(28), 5114-5124.
17. Liu, P.; Li, Z.; Zhu, M.; Sun, Y.; Li, Y.; Wang, H.; Dwan, Y. Preparation of EGFR monoclonal antibody conjugated nanoparticles and targeting to hepatocellular carcinoma. J. Mater. Sci. Mater. Med., 2010, 21(2), 551-556.
18. Zhao, H.Z.; Yue, L.; Yung, L. Selectivity of folate conjugated polymer micelles against different tumor cells. Int. J. Pharm., 2008, 349(1-2), 256-268.
19. Leamon, C.P.; Reddy, J.A. Folate-targeted chemotherapy. Adv. Drug Deliv. Rev., 2004, 56(8), 1127-1141.
20. Park, E.K.; Lee, S.B.; Lee, Y.M. Preparation and characterization of methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials, 2005, 26(9), 1053-1061.
21. Goldberg, M.; Langer, R.; Jia, X.Q. Nanostructured materials for applications in drug delivery and tissue engineering. J. Biomater. Sci. Polym. Ed., 2007, 18(3), 241-268.
22. Yang, S.J.; Lin, F.H.; Tsai, H.M.; Lin. C.F.; Chin, H.C.; Wong, J.M.; Shieh, M.J. Alginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasms. Biomaterials, 2011, 32(8), 2174-2182.
23. Berscht, P.C.; Nies, B.; Liebendörfer, A.; Kreuter, J. Incorporation of basic fibroblast growth factor into methylpyrrolidinone chitosan fleeces and determination of the in vitro release characteristics. Biomaterials, 1994, 15(8), 593-600.
24. Thanou, M.; Verhoef, J.C.; Junginger, H.E. Chitosan and its derivatives as intestinal absorption enhancers. Adv. Drug Deliv. Rev., 2001, 50(1), 91-101.
25. Thanou, M.; Verhoef, J.C.; Junginger, H.E. Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Deliv. Rev., 2001, 52(2), 117-26.
26. Agnihotri, S.A.; Mallikarjuna, N.N.; Aminabhavi, T.M. Recent advances on chitosan based micro-and nanoparticles in drug delivery. J. Control. Release, 2004, 100(1), 5-28.
27. Qi, L.; Xu, Z.; Jiang, X.; Hu, C.; Zou, X. Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr. Res., 2004, 339(16), 2693-2700.
28. Du, J.; Zhang, S.; Sun, R.; Zhang, L.F.; Xiong, C.D.; Peng, Y.X. Novel polyelectrolyte carboxymethyl konjac glucomannan-chitosan nanoparticles for drug delivery.II. Release of albumin in vitro. J. Biomed. Mater. Res. Part B, 2005, 72(2), 299-304.
29. Yang, X.D.; Zhang, Q.Q.; Wang, Y.S.; Chen, H.; Zhang, H.Z.; Gao, F.P.; Liu, L.R. Self-aggregated nanoparticles from methoxy poly(ethylene glycol)-modified chitosan: Synthesis; characterization; aggregation and methotrexate release in vitro. Colloids Surf. B Biointerfaces, 2008, 61(2), 125-131.
30. Breitenbach, A.; Kissel, T. Biodegradable comb polyesters: Part 1: synthesis, characterisation and structural analysis of PLA and PLGA grafted onto water-soluble P VA as backbone. Polymers, 1998, 39(14), 3261-3271.
31. Pistel, K.F.; Breitenbach, A.; Zange, R.; Kissel, T. Brush-like biodegradable polyesters, Part III, protein release from microspheres of poly(vinylalcohol)-graft-poly(D, L-lactic-co-glycolic acid). J. Control. Release, 2001, 73(1), 7-20.
32. Zhang, W.; Shi, Y.; Chen, Y.Z.; Ye, J.; Sha, X.Y.; Fang, X.L. Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials, 2011, 32(11), 2894-2906.
33. Wang, J.F.; Liu, W.M.; Tu, Q.; Wang, J.C.; Song, N.; Zhang, Y.R.; Nie, N.; Wang, J.Y. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery. Biomacromolecules, 2011, 12(1), 228-234.
34. Chorny, M.; Fishbein, I.; Golomb, G. Drug delivery systems for treatment of restenosis. Crit. Rev. Ther. Drug Carr. Syst., 2000, 17(3), 249-284.
35. Fishbein, I.; Chorny, M.; Rabinovich, L.; Banai, S.; Gati, I.; Golomb, G. Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis, J. Control. Release, 2000, 65(1), 221-229.
36. Soppimath, K.S.; Aminabhavi, T.M.; Kulkarni, A.R.; Rudzinski, W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release, 2001, 70(1), 1-20.
37. Song, C.; Labhasetwar, V.; Cui, X.; Underwood, T.; Levy, R.J. Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model. J. Control. Release, 1998, 54(2), 201-211.
38. Mu, L.; Feng, S.S. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J. Control. Release, 2003, 86(1), 33-48.
39. Mosqueira, V.C.F.; Legrand, P.; Morgat, J.L.; Vert, M.; Mysiakine, E.; Gref, R.; Devissaguet, J.P.; Barratt, G. Biodistribution of longcirculating PEG-grafted Nanocapsules in mice: effects of PEG chain length and density. Pharm. Res., 2001, 18(10), 1411-1419.
40. Dong, Y.C.; Feng, S.S. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials, 2004, 25(14), 2843-2849.
41. Zhang, Y.; Zhuo, R.X. Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly (ethylene glycol) and polycapr o lactone. Biomaterials, 2005, 26(33), 6736-6742.
42. Ge, H.X.; Hu, Y.; Jiang, X.Q.; Cheng, D.M.; Yuan, Y. Y; Bi, H.; Yang, C.Z. Preparation, characterization and drug release behaviors of drug nimodipine-loaded p o ly(s-caprolactone)-poly (ethylene oxide)-poly(s- caprolactone) amphiphilic triblock copolymer micelles. J. Pharm. Sci., 2002, 91(1), 463-473.
43. Yoo, H.S.; Park, T.G. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J. Control Release, 2001, 70(1-2), 63-70.
44. Gref, R.; Minamitake, Y; Peracchia, M.T.; Trubetskoy, V.; Torchilin, V.; Langer, R. Biodegradable long-circulating polymeric nanospheres. Science, 1994, 263(18), 1600-1603.
45. Shields, R.; Harris, J.; Davis, M. Suitability of poly(ethylene glycol) as dilution indicator in the human colon. Gastroenterology, 1968, 54(1), 331-333.
46. Huang, S.J.; Sun, T.H.; Feng, T.H.; Sung, K.H.; Lui WL.; Wang, L.F. Folate-mediated chondroitin sulfate-Pluronic®127 nanogels as a drug carrier. Eur. J. Pharm. Sci., 2009, 38(1), 64-73.
47. Lee, E.S.; Oh, Y.T.; Youn, Y.S.; Nam, M.; Park, B.; Yun, J.; Kim, J.H.; Song, H.T.; Oh, K.T. Binary mixing of micelles using Pluronics for a nano-sized drug delivery system. Colloids Surf. B Biointerfaces, 2011, 82(1), 190-195.
48. Wang, Y.Z.; Li, Y.J.; Han, L.M.; Sha, X. Y; Fang, X.L. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of f o late-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines. Int. J. Pharm., 2007, 337(1-2), 63-73.
49. Batrakova, E.V.; Li, S.; Li, Y.L.; Alakhov, V. Y; Elmquist, W.F.; Kabanov, A.V. Ditribution kinetics of a micelle-forming block copolymer Pluronic P85. J. Control. Release, 2004, 100(3), 389-397.
50. Pec, E.A.; Wout, Z.G.; Johnston, T.P Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the rat. J. Pharm. Sci, 1992, 81(7), 626-630.
51. Grindel, J.M.; Jaworski, T.; Piraner, O.; Emanuele, R.M.; Balasubramanian, M. Distribution, metabolism and excretion of a novel surface-avtive agent, purified poloxamer 188, in rats, dogs and humans. J. Pharm. Sci, 2002, 91(9), 1936-1947.
52. Song, H.; He, R.; Wang, K.; Ruan, J.; Bao, C.C.; Li, N.; Ji, J.J.; Cui, D.X. Anti-HIF-1a antibody-conjugated pluronic triblock copolymers encapsulated with Paclitaxel for tumor targeting therapy. Biomaterials, 2010, 31(8), 2302-2312.
53. Yang, T.F.; Chen, C.N.; Chen, M.C.; Lai, C.H.; Liang, H.F.; Sung, H.W. Shell-crosslinked Pluronic L121 micelles as a drug delivery vehicle. Biomaterials, 2007, 28(4), 725-734.
54. Batrakova, E.V.; Kabanov, A.V. Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J. Control. Release, 2008, 130(2), 98-106.
55. Ganta, S.; Devalapally, H.; Shahiwala, A.; Amiji, M. A review of stimuli-responsive nanocarriers for drug and gene delivery. J. Control. Release, 2008, 126(3), 187-204.
56. Hillaireau, H.; Couvreur, P. Nanocarriers' entry into the cell: relevance to drug delivery. Cell. Mol. Life Sci, 2009, 66(17), 2873-2896.
57. Park, J.H.; Lee, S.; Kim, J.H.; Park, K.; Kim, K.; Kwon, I.C. Polymeric nanomedecine for cancer therapy. Prog. Polym. Sci, 2008, 33(1), 113-137.
58. Pan. J.; Feng, S.S. Targeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticles. Biomaterials, 2008, 29(17), 2663-2672.
59. Suna, B.F.; Ranganathan, B.; Feng, S.S. Multifunctional poly(D, L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Biomaterials, 2008, 29(4), 475-486.
60. Liang, H.F; Chen, C.T.; Chen, S.C.; Kulkarni, A. R.; Chiu, Y.L.; Chen, M.C.; Sung, H.W. Paclitaxel-loaded poly(y-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Biomaterials, 2006, 27(9), 2051-2059.
61. Lee, A.L.Z.; Wang, Y; Cheng, H.Y; Pervaiz, S.; Yang, Y Y The co-delivery of Paclitaxel and Herceptin using cationic micellar nanoparticles. Biomaterials, 2009, 30(5), 919-927.
62. Liu, S.Q.; Wiradharma, N; Gao, S.J.; Tong, Y-W.; Yang, Y Y Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs. Biomaterials, 2007, 28(7), 1423-1433.
63. Liu, J.Y; Huang, W.; Pang, Y; Zhu, X.Y; Zhou, Y.F.; Yan, D.Y The in vitro bio compatibility of self-assembled hyperbranched cop o ly phosphate nanocarriers. Biomaterials, 2010, 31(21), 5643-5651.
64. Chan, J.M.; Zhang, L.F; Yuet, K.P.; Liao, G.; Rhee, J.W.; Langer, R.; Farokhzad, O.C. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials, 2009, 30(8), 1627-1634.
65. Duncanson, W.J.; Figa, Mi.A.; Hallock, K.; Zalipsky, S.; Hamilton, J.A.; Wong, J.Y. Targeted binding of PL A microparticles with lipid-PEG-tethered ligands. Biomaterials, 2007, 28(33), 4991-4999.
66. Liu, S.Q.; Tong, Y.W.; Yang, Y Y Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N- isopropylacrylamide-co-N, Ndimethylacrylamide)-b-poly(D, L-lactide-co-glycolide) with varying compositions. Biomaterials, 2005, 26(24), 5064-5074.
67. Hou, D.Z.; Xie, CS.; Huang, K.J.; Zhu, C.H. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials, 2003, 24(10), 1781-1785.
68. Lee, S.Jin.; Koo, H.; Jeong, H.; Huh, M.S.; Choi, Y; Jeong, S.Y; Byun, Y; Choi, K.; Kim, K.; Kwon, I.C. Comparative study of photo sensitizer loaded and conjugated glycol chitosan nanoparticles for cancer therapy. J. Control. Release, 2011, 152(1), 21-29.
69. Tang, R.P; Ji, W.H.; Panus, D.; Palumbo, R.N.; Wang, C. Block copolymer micelles with acid-labile ortho ester side-chains: Synthesis, characterization, and enhanced drug delivery to human glioma cells. J. Control. Release, 2011, 151(1), 18-27.
70. Kataoka, K.; Matsumoto, T.; Yokoy ama, M.; Okano, T.; Sakurai, Y; Fukushima, S.; Okamoto, K.; Kwon, G.S. Doxorubicin-loaded poly(ethylene g lyc o l)-poly(ß-benzyl-L aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. J. Control. Release, 2000, 64(1-3), 143-153.
71. Aliabadi, HM.; Mahmud, A.; Sharifabadi, A.D.; Lavasanifar, A. Micelles of methoxy polyethylene oxide)-b-poly(s-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A. J. Control. Release, 2005, 104(2), 301-311.
72. Abdelwahed, W.; Degobert, G.; Stainmesse, S.; Fessi, H. Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv. Drug Deliv. Rev, 2006, 58(15), 1688-1713.
73. Santos, N.D.; Cox, K.A.; McKenzie, CA.; Baarda, F.V; Gallagher, R.C.; Karlsson, G.; Edwards, K.; Mayer, L.D.; Allen, C; Bally, M.B. pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanol. Biochim. Biophys. Acta Biomembr, 2004, 1661(1), 47-60.
74. Lavasanifar, A.; Samuel, J.; Kwon, G.S. Micelles self-assembled from poly (ethylene oxide)-block-poly(N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B. J. Control. Release, 2001, 77(1-2), 155-160.
75. Hasan, A.S.; Socha, M.; Lamprecht, A.; Ghazouani, FE.; Sapin, A.; Hoffman, M.; Maincent, P.; Ubrich, N. Effect of the microencapsulation of nanoparticles on the reduction of burst release. Int. J. Pharm., 2007, 344(1-2), 53-61.
76. Seow, W.Yang.; Xue, J.M.; Yang, Y Y Targeted and intracellular delivery of paclitaxel using multi-functional polymeric micelles. Biomaterials, 2007, 28(9), 1730-1740.
77. Mu, CF.; Balakrishnan, P.; Cui, F.D.; Yin, Y.M.; Lee, Y.B.; Choi, H.G.; Yong, CS.; Chung, S.J.; Shim, CK.; Kim, D.D. The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel. Biomaterials, 2010, 31(8), 2371-2379.
78. Zhang, Z.P; Lee, S.H.; Feng, S.S. Folate-decorated poly(lactide-co- glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials, 2007, 28(10), 1889-1899.
79. Hu, F.X.; Neoh, K.G.; Kang, E.T. Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles. Biomaterials, 2006, 27(33), 5725-5733.
80. Lee, M.K.; Lim, S.J.; Kim, CK. Preparation, characterization and in vitro cytotoxicity of paclitaxel loaded sterically stabilized solid lipid nanoparticles. Biomaterials, 2007, 28(12), 2137-2146.
81. Upadhyay, K.K.; Bhatt, A.N.; Mishra, A.K.; Dwarakanath, B.S.; Jain, S.; Schatz, C; Meins, J.L.; Farooque, A.; Chandraiah, G.; Jain, A.K.; Misra, A.; Lecommandoux, S. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(y-benzyl L-glutamate)-b-hyaluronan polymersomes. Biomaterials, 2010, 31(10), 2882-2892.
82. Zhu, S.; Hong, M.H.; Tang, G.T.; Qian, L.L.; Lin, J.Y; Jiang, YY; Pei, Y Y Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: The effects of PEGylation degree and drug conjugation style. Biomaterials, 2010, 31(6), 1360-1371.
83. Bae, B.C.; Na, K. S elf-quenching polysaccharide-based nanogels of pullulan/folate photo sensitizer conjugates for photodynamic therapy. Biomaterials, 2010, 31(24), 6325-6335.
84. Ringsdorf, H. Structure and properties of pharmacologically active polymers. J. Polym. Sci Polym. Symp., 1975, 51(1), 135-153.
85. Park, J.H.; Saravanakumar, G.; Kim, K.; Kwon, I.C. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv. Drug Deliv. Rev, 2010, 62(1), 28-41.
86. Seymour, L.W.; Ulbrich, K.; Wedge, S.R.; Hume, I.C; Strohalm, J.; Duncan, R. N-(2-hydroxy pro pyl)methacrylamide copolymers targeted to the hepatocyte galactosereceptor: pharmacokinetics in DBA2 mice. Br. J. Cancer, 1991, 63(6), 859-866.
87. Khandare, J.; Minko, T. Polymer-drug conjugates: Progress in polymeric prodrugs. Prog. Polym. Sci, 2006, 31(4), 359-397.
88. Xie, Z.G.; Guan, H.L.; Chen, X.S.; Lu, C.H.; Chen, L.; Hu, X.; Shi, Q.; Jing, X.B. A novel polymer-paclitaxel conjugate based on amphiphilic triblock copolymer. J. Control. Release, 2007, 117(2), 210-216.
89. Xie, Z.G.; Lu, T.C.; Chen, X. S.; Lu, C.H.; Zheng, Y.H.; Jing, X.B. Triblock poly (lactic acid)-b-poly(ethylene glycol)-b-poly (lactic acid)/paclitaxel conjugates: Synthesis, micellization, and cytotoxicity. J. Appl. Polym. Sci., 2007, 105(4), 2271-2279.
90. Moghimi, S.M.; Hunter, A.C.; Murray, J.C. Nanomedicine: current status and future prospects. FASEB J, 2005, 19(3), 311-330.
91. Ehrlich, P. The collected papers of Paul Ehrlich, Pergamonc, London, 1960, p. 3.
92. Bae, Y.H. Drug targeting and tumor heterogeneity. J. Control. Release, 2009, 133(1), 2-3.
93. Nie, S.M.; Xing, Y.; Kim, G.J.; Simons, J.W. Nanotechnology applications in cancer. Annu. Rev. Biomed. Eng, 2007, 9, 257-288.
94. Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res., 1986, 46(12), 6387-6392.
95. Duncan, R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov., 2003, 2(5), 347-360.
96. Jain, R.K. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J. Control. Release, 2001, 74(1-3), 7-25.
97. Jain, R.K. Understanding barriers to drug delivery: high resolution in vivo imaging is key. Clin. Cancer Res., 1999, 5(7), 1605-1606.
98. Negussie, A.H.; Miller, J.L.; Reddy, G.; Drake, S.K.; Wood, B.J.; Dreher, M.R. Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome. J. Control. Release, 2010, 143(2), 265-273.
99. Sui, G.D.; Wang, J.Y.; Lee, C.C.; Lu, W.X.; Lee, S.P.; Leyton, J.V.; Wu, A.M.; Tseng, H. R. Solution-phase surface modification in intact poly(dimethylsiloxane) microfluidic channels. Anal. Chem., 2006, 78(15), 5543-5551.
100. Díaz-Moscoso, A.; Vercauteren, D.; Rejman, J.; Benito, J.M.; Mellet, C.O.; De Smedt, S.C.; García-Fernández, J.M. Insights in cellular uptake mechanisms of pDNA-polycationic amphiphilic cyclodextrin nanoparticles (CDplexes). J. Control. Release, 2010, 143(3), 318-325.
101. Thibault, M.; Astolfi, M.; Tran-Khanh, N.; Lavertu, M.; Darras, V.; Merzouki, A.; Buschmann, M.D. Excess polycation mediates efficient chitosan-based gene transfer by promoting lysosomal release of the polyplexes. Biomaterials, 2011, 32(20), 4639-4646.
102. Allen, T.M. Ligand-targeted therapeutics in anticancer therapy. Nature, 2002, 2, 750-763.
103. Cho, K.; Wang, X.; Nie, S.; Chen, Z.G.; Shin, D.M. Therapeutic nanoparticles for drug delivery in cancer. Clin. Cancer Res., 2008, 14(5), 1310-1316.
104. Daniels, T.R.; Delgado, T.; Helguera, G.; Penichet, M.L. The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clin. Immunol., 2006, 121(2), 159-176.
105. Minko, T. Drug targeting to the colon with lectins and neoglycoconjugates. Adv. Drug Deliv. Rev., 2004, 56(4), 491-509.
106. Lurje, G.; Lenz, H.J. EGFR signaling and drug discovery. Oncology, 2009, 77 (6), 400-410.
107. Lu, Y.J.; Low PS. Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects. J. Control. Release, 2003, 91(1), 17-29.
108. Lu, Y.J.; Sega, E.; Leamon, C.P.; Low, P.S. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential. Adv. Drug Deliv. Rev., 2004, 56(8), 1161-1176.
109. Saul, J.M.; Annapragada, A.; Natarajan, J.V.; Bellamkonda, R.V. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J. Control. Release, 2003, 92(1), 49-67.
110. Sudimack, J.; Lee, R.J. Targeted drug delivery via the folate receptor. Adv. Drug Deliv. Rev., 2000, 41(2), 147-162.
111. Ross, J.F.; Chaudhuri, P.K.; Ratnam, M. Differential regulation of folate receptor isoforms in normal and malignant-tissues in vivo and in established cell-lines-physiological and clinical implications. Cancer, 1994, 73(9), 2432-2443.
112. Park, E.K.; Kim, S.Y.; Lee, S.B.; Lee, Y.M. Folate-conjugated methoxy poly(ethylene glycol)/poly(ε-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. J. Control. Release, 2005, 109(1), 158-168.
113. Yoo, H.S.; Park, T.G. Folate receptor targeted biodegradable polymeric doxorubicin micelles. J. Control. Release, 2004, 96(2), 273-283.
114. Lee, Y.K. Preparation and characterization of folic acid linked poly-(L-glutamate) nanoparticles for cancer targeting. Macromol. Res, 2006, 14(3), 387-393.
115. Shmeeda, H.; Mak, L.; Tzemach, D.; Astrahan, P.; Tarshish, M.; Gabizon, A. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors. Mol. Cancer Ther., 2006, 5(4), 818-824.
116. Wu, J.; Liu, Q.; Lee, R.J. A folate receptor-targeted liposomal formulation for paclitaxel. Int. J. Pharm., 2006, 316(1-2), 148-153.
117. Gref, R.; Domb, A.; Quellec, P.; Blunk, T.; Muller, R.H.; Verbavatz, J.M. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv. Drug Deliv. Rev., 1995, 16(2), 215-233.
118. Canal, F.; Vicent, María.J.; Pasut, G.; Schiavon, O. Relevance of folic acid/polymer ratio in targeted PEG-epirubicin conjugates. J. Control. Release, 2010, 146(3), 388-399.
119. Liang, B.; He, M.L.; Xiao, Z.Peng.; Li, Y.; Chan, C.Y.; Kung, H.F.; Shuai, X.T.; Peng, Y. Synthesis and characterization of folate-PEG-grafted- hyperbranched-PEI for tumor-targeted gene delivery. Biochem. Biophys. Res. Commun., 2008, 367(2), 874-880.
120. Huff, T.B.; Tong, L.; Zhao, Y.; Hansen, M.N.; Cheng, J.X.; Wei, A. Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine (Lond), 2007, 2(1), 125-132.
121. Schneider, R.; Schmitt, F.; Frochot, C.; Fort, Y.; Lourette, N.; Guillemin, F.; Mullerd J.F.; Barberi-Heyob, M. Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy. Bioorgan. Med. Chem., 2005, 13(8), 2799-2808.
122. Nukolova, N.V.; Oberoi, H.S.; Cohen, S.M.; Kabanov, A.V.; Bronich, T.K. Folate-decorated nanogels for targeted therapy of ovarian cancer. Biomaterials, 2011, 32(23), 5417-5426.
123. Chandrasekar, D.; Sistla, R.; Ahmad, F.J.; Khar, R.K.; Diwan, P. V. The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats. Biomaterials, 2007, 28(3), 504-512.
124. Wang, H.J.; Zhao, P.Q.; Liang, X.F.; Gong, X.Q.; Song, T.; Niu, R.F.; Chang, J. Folate-PEG coated cationic modified chitosan-Cholesterol liposomes for tumor-targeted drug delivery. Biomaterials, 2010, 31(14), 4129-4138.
125. Liu, Y.T.; Li, K.; Pan, J.; Liu, B.; Feng, S.S. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel. Biomaterials, 2010, 31(2), 330-338.
126. 2 nanoparticles for targeting ovarian cancer cells. Biomaterials, 2011, 32(8), 2166-2173.
127. Lu, P.L.; Chen, Y.C.; Ou, T.W.; Chen, H.H.; Tsai, H.C.; Wen, C.J.; Lo, C.L.; Wey, S.P.; Lin, K.J.; Yen, T.C.; Hsiue, G.H. Multifunctional hollow nanoparticles based on graft-diblock copolymers for doxorubicin delivery. Biomaterials, 2011, 32(8), 2213-2221.